baber/WOPTO huggingface dataset:
Patent MX-2018001761-A (MX)
Title: Abnormality diagnostic device for exhaust emission control device for internal combustion engine.
Inventor: HIROMASA NISHIOKA
IPC: F01N3/08
Filed: 2018-02-09
Abstract: PROBLEM TO BE SOLVED: To improve accuracy of an abnormality diagnosis in the case where the abnormality diagnosis is made when a temperature of an exhaust emission control catalyst is low.SOLUTION: An abnormality diagnostic device for an exhaust emission control device for an internal combustion engine includes a control device for adding an additive to an exhaust emission control catalyst when a temperature of the exhaust emission control catalyst is a predetermined temperature or lower. The control device makes an abnormality diagnosis of the exhaust emission control catalyst on the basis of exhaust gas purification capacity of the exhaust emission control catalyst. In the case where the abnormality diagnosis of the exhaust emission control catalyst is made when the temperature of the exhaust emission control catalyst is the predetermined temperature or lower, the amount of the additive to be supplied to the exhaust emission control catalyst is reduced, compared to the case where th e abnormality diagnosis of the exhaust emission control catalyst is not made when the temperature of the exhaust emission control catalyst is the predetermined temperature or lower.SELECTED DRAWING: Figure 5.
Patent MX-2018004109-A (MX)
Title: Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies.
Inventor: DONALD LANDRY
IPC: A61K31/5377
Filed: 2016-10-05
Abstract: The present application discloses compounds which are activators of autophagic flux and pharmaceutical compositions comprising said activators. It further discloses use of said compounds and pharmaceutical compositions in the treatment of neurodegenerative diseases, particularly proteinopathies and tauopathies such as Alzheimer's disease. It further discloses methods of enhancing autophagic flux.
Patent MX-2018004718-A (MX)
Title: Receiving apparatus and decoding method thereof.
Inventor: Jung- Hyun PARK
IPC: H04L1/00
Filed: 2016-10-19
Abstract: A receiving apparatus includes: a first decoder configured to decode a signal transmitted through a first layer from a layered division multiplexing (LDM) signal using a parity check matrix to generate low density parity check (LDPC) information word bits and parity bits; an encoder configured to encode the LDPC information word bits, generated by decoding the signal transmitted through the first layer, using the parity check matrix to generate parity bits corresponding only to preset columns in the parity check matrix; and a second decoder configured to decode a signal obtained by removing, from the LDM signal, a signal corresponding to the LDPC information word bits generated by decoding the signal transmitted through the first layer, the parity bits generated by the encoder, and the parity bits generated by the first decoder except the parity bits generated by the encoder, thereby to generate information word bits transmitted through a second layer.
Patent MX-2018007401-A (MX)
Title: Device for sealing pipelines.
Inventor: MAURO ODORI
IPC: F16L55/124
Filed: 2016-12-28
Abstract: This inventions relates to a plugging machine (100) and a rigid tube (2) provided with a stationary disc (3) integral with the bottom of the tube (2) and oriented almost orthogonal to the tube (2), with a movable disc (4) paired with the stationary disc (3). A dealing ring (50) of a resilient material is located between the discs (3, 4) and compressed when the movable disc (4) is pressed against the stationary disc (3) to adhere to an inner surface of the pipeline (200). The sealing ring (50) is coaxial with respect to the pipeline (200). The movement of the movable disc (4) is determined by raising or lowering a control rod (6) within the tube (2) by means of sloping sliders (70) made in the lower portion of the rod (6) which engage in respective grooves (44), likewise sloping, made in an axial shank (40) associated with the movable disc (4) and sliding inside an axial opening of the stationary disc (3). A component of a force is generated which is parallel to the axis of the discs (3,4). The axis is raised or lowered by rotation of a threaded ring (82) engaging in a threading mate at the top (6A) of the rod (6).
Patent MX-2018009219-A (MX)
Title: Novel crystalline form of 1-(5-(2,4-difluorophenyl)-l-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine salt.
Inventor: AERI KIM
IPC: A61K31/40
Filed: 2017-03-17
Abstract: The present invention provides a novel crystalline form I of hydrochloride, a crystalline form II of hydrochloride, a crystalline form of succinate, a crystalline form of tartrate, a crystalline form I of fumarate and a crystalline form II of fumarate of 1-(5-(2,4- difluorophenyl)- 1 -((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N- methylmetlianamine. The above-described novel crystalline forms have high solubility in water and excellent stability under moisture-proof conditions and high-humidity exposure conditions, and thus can be pharmaceutically used.
Patent MX-2018009849-A (MX)
Title: Drug combinations and methods to stimulate embryonic-like regeneration to treat diabetes and other diseases.
Inventor: VALTER D LONGO
IPC: A23L33/00
Filed: 2017-02-15
Abstract: Stem cell-based therapies can potentially reverse organ dysfunction and diseases but the removal of impaired tissue and reactivation of the program leading to organ regeneration pose major challenges. In mice, a four-day fasting mimicking diet (FMD) induces a step-wise expression of Sox17 and Pdx-1, resembling that observed during pancreatic development and followed by Ngn3-driven generation of insulin-producing ß-cells. FMD cycles restore insulin secretion and glucose homeostasis in both a type 2 and type 1 diabetes mouse models. In human type 1 diabetes pancreatic islets, fasting conditions reduce PKA and mTOR activity and induce Sox2 and Ngn3 expression and insulin production. The effects of the FMD are reversed by IGF-1 treatment and recapitulated by PKA and mTOR inhibition. These results indicate that a FMD promotes the reprogramming of pancreatic cells to restore insulin generation in islets from T1D patients and reverse both T1D and T2D phenotypes in mouse models.
Patent MX-2018014329-A (MX)
Title: Hot-fill container having vacuum absorption sections.
Inventor: Lesley CORKER
IPC: B65D1/02
Filed: 2017-05-22
Abstract: The present disclosure describes a hot-fill container for use with a hot-filling process. The container comprises vacuum absorption sections that resist partial collapse and uncontrolled deformation of the container's walls during the hot-filling process. The vacuum absorption sections are asymmetrically-formed and include respective edge portions and panel portions configured to deform and pivot about a linear part of the edge portions when a vacuum is created inside the container. The edge portions have a curvilinear part that is adapted to comfortably receive and engage a user's fingers during use of the container, making the container more user friendly. The vacuum absorption sections are arranged about the container's central longitudinal axis such that their respective panel portions substantially form the sides of a polygon when viewed in top plan view. The polygon appears to be inscribed within an otherwise circular container periphery.
Patent MX-2018015104-A (MX)
Title: Device and method for determining a local property of a biological tissue.
Inventor: HENNING EBERT
IPC: A61B18/14
Filed: 2018-12-05
Abstract: The disclosure relates to an ablation catheter for determining a local property of a biological tissue, said catheter having a flexible shaft, a data processing device, and an NMR sensor, which is arranged at the distal end of the shaft and is connected to the data processing device, wherein the NMR sensor comprises a first sensor element for generating a static magnetic field and a second sensor element for generating a magnetic alternating field, wherein the distal end of the shaft can be arranged adjacently to the point of the tissue to be measured, wherein the data processing device is designed to determine the local property of the tissue at this point on the basis of a signal of the NMR sensor transmitted to the data processing device. The disclosure also relates to a corresponding method.
Patent MX-2018015761-A (MX)
Title: Compositions comprising bacterial strains.
Inventor: ANNICK BERNALIER-DONADILLE
IPC: A61K35/74
Filed: 2017-07-13
Abstract: The invention provides compositions comprising one or more bacterial strains for treating preventing diarrhea and/or constipation.
Patent MX-2019002832-A (MX)
Title: Electrically conductive contact element for an electric plug connector.
Inventor: STEFAN MAYER
IPC: H01R24/20
Filed: 2017-08-31
Abstract: The invention relates to an electrically conductive contact element (2) for an electric plug connector. The electrically conductive contact element (2) comprises a contact region (4) for making detachable electric contact with a mating contact element of a mating plug connector, and comprises a cable connecting region (6) for the connection of a cable. The contact element (2) comprises a cooling cavity (24), which opens into a distal opening (22) of the cable connecting region (6) which is arranged opposite the contact region (4).
Patent MX-2019008570-A (MX)
Title: Development cartridge having sealing member.
Inventor: JONG IN KIM
IPC: G03G15/08
Filed: 2018-01-17
Abstract: Disclosed is a development cartridge detachable from a main body of an image forming apparatus. The development cartridge includes a lateral waste toner sealing member contacting an end portion of a photosensitive drum in a lengthwise direction of the photosensitive drum to prevent a waste toner from leaking through the end portion of the photosensitive drum, and a photosensitive frame including a waste toner container to contain the waste toner, a first attachment surface, to which the lateral waste toner sealing member is attached, and a side wall to form a boundary at an upstream side of the first attachment surface with respect to a rotation direction of the photosensitive drum. The lateral waste toner sealing member includes an opposite surface facing the side wall, and a protrusion protruding towards the side wall is provided on the opposite surface.
Patent MX-2019012276-A (MX)
Title: Coating materials generating structured surfaces.
Inventor: Andreas janssen
IPC: C09D7/40
Filed: 2018-04-10
Abstract: The invention relates to coating material compositions, comprising (i) at least one polyol component (A), (ii) at least one crosslinking agent component (B) having groups reactive to hydroxyl groups of component (A), (iii) at least one polyamide component (P1) in which the acid amide groups are linked by a saturated, aliphatic hydrocarbon radical having 6 to 10 carbon atoms and which is employed in particulate form, wherein the particle size distribution of the primary particles thereof has a median particle size (D50) of 20 to 100 µm and (iv) at least one polycarboxamide component (P2), characterized in that the polycarboxamide component (P2) has the following structural formula, (I), wherein s = 1, 2 or 3, t = 0 or 1, and s + t = 2 or 3, R represents a special (s+t)-valent organic radical and at least one of the radicals R1 and R2 bears at least one hydroxyl group. The invention also relates to the production of such coating material compositions, to the use thereof in the production of multilayer lacquers and to the use of a combination of (P1) and (P2) as an additive in coating material compositions for producing textured lacquer layers, in particular textured clearcoat layers.
Patent MX-2019014430-A (MX)
Title: Human antibodies to bet v 1 and methods of use thereof.
Inventor: KAMAT VISHAL
IPC: A61K39/00
Filed: 2018-05-31
Abstract: Provided herein are antibodies that bind Fagales allergens, Fagales related allergens, birch pollen, or Bet v 1, compositions comprising the antibodies, nucleic acids encoding the antibodies, and methods of using the antibodies. According to certain embodiments, the antibodies are fully human monoclonal antibodies that bind to Bet v 1. The antibodies are useful for binding Bet v 1 in vivo, thus preventing binding of the allergen to pre-formed IgE on the surface of mast cells or basophils. In doing so, the antibodies act to prevent the release of histamine and other inflammatory mediators from mast cells and/or basophils, thus ameliorating the untoward response to the Fagales allergens in sensitized individuals.
Patent MX-2020000690-A (MX)
Title: Heterocyclic compounds as adenosine antagonists.
Inventor: CHAKRAVARTY SARVAJIT
IPC: A61K31/495
Filed: 2018-07-18
Abstract: Aminopyrazine compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.
Patent MX-2020000988-A (MX)
Title: Low temperature cure coating formed via polarity-facilitated catalyst migration between layers in a double layer curing mechanism.
Inventor: DECEMBER TIMOTHY S
IPC: C09D5/00
Filed: 2018-07-02
Abstract: A double coating, curing method, cured coating, and kit are provided. A first layer of the double coating can be a first cure coating composition, which has a first hydroxy-functional resin, a first crosslinking agent, and a non-polar catalyst. A second layer of a second cure coating composition can have a second hydroxy-functional resin, a second crosslinking agent, and a polar catalyst. The non-polar catalyst catalyzes crosslinking between the second hydroxy-functional resin and crosslinking agent, and not between the first hydroxy-functional resin and crosslinking agent. The polar catalyst catalyzes crosslinking between the first hydroxy-functional resin and crosslinking agent, and not between the second hydroxy-functional resin and crosslinking agent. The polarity of the catalysts can facilitate catalyst migration from one layer to the other. The separate compositions can be shelf-stable and/or the curing can occur at low temperature.
Patent MX-2020003170-A (MX)
Title: Modular system for constructing structures.
Inventor: BORJA RAMÍREZ VICENTE
IPC: E04B1/58
Filed: 2020-03-20
Abstract: The present invention relates to a modular system for constructing structures, including a plurality of structural modules depending on the structure. Herein, each module comprises a plurality of nodes for joining and fixing elements characterizing said module, a plurality of strings arranged horizontally and joined at their ends to a respective node, diagonals arranged diagonally or obliquely joined at their ends to said node, fixation supports inserted and fixed in each of the nodes by a screw, fastening the strings and the diagonals therein.
Patent MX-2020006257-A (MX)
Title: Sprocket guard.
Inventor: CODY MICHAEL
IPC: B62J13/00
Filed: 2018-12-11
Abstract: A sprocket guard (10) comprising a sprocket (20) having sprocket radial spokes, and having teeth on an outer perimeter, the teeth disposed in a first plane, each sprocket radial spoke communicating with a first cylindrical surface, a circular member (10) having circular member radial spokes, and each circular member radial spoke communicating with a second cylindrical surface, a collar (30) having an outer cylindrical surface, a fastener engaging the collar, the first cylindrical surface and the second cylindrical surface engaging the outer cylindrical surface, all coplanar in the first plane, and the first plane is offset from second plane.
Patent MX-2020008095-A (MX)
Title: System and method for characterizing size and charge variant drug product impurities.
Inventor: WANG SHUNHAI
IPC: C07K16/00
Filed: 2019-01-28
Abstract: Systems and methods for characterizing size and charge variant protein drug product impurities are provided.
Patent MX-2020008170-A (MX)
Inventor: ZHANG XIAOQUAN
IPC: C08F236/06
Filed: 2019-12-14
Abstract: La presente invención divulga un polímero de metil metacrilato butadieno estireno (MBS) opaco, de alto impacto y fácil de procesar para cloruro de polivinilo (PVC) y un procedimiento de preparación del mismo, y se refiere al campo técnico de preparación de aditivos de PVC. El MBS opaco, de alto impacto y fácil de procesar para PVC tiene una estructura de núcleo-centro-cubierta (tres capas) e incluye los siguientes componentes en masa: 1-20% de núcleo, 70-85% de centro y 5-20% de cubierta. El núcleo es un copolímero semiduro y ligeramente reticulado de un monómero de estireno (St) y un monómero de acrilato. El centro es un polímero de butadieno (BD)-St blando y ligeramente reticulado con una baja temperatura de transición vítrea. La cubierta es un copolímero de St, acrilato de butilo y metacrilato de metilo (MMA) con una alta temperatura de transición vítrea. La presente invención resuelve los problemas de baja resistencia al impacto y fluidez de procesamiento deficiente del MBS existente para productos de PVC opaco.
Patent MX-2020010589-A (MX)
Title: Balance board.
Inventor: METCALFE DANIEL BENJAMIN
IPC: A63B22/18
Filed: 2019-04-09
Abstract: An exercise device having a top surface, the top surface having a left side and a right side, and front and back sides, where the front side includes a location for a user to rest their foot on the top surface in a central part of the top surface, and includes at least one handle location allowing a user to hold on relative to the top surface, where the handle location is attached to the top surface, and also having a bottom surface, and where the bottom surface includes a central pivot point between side to side at the central part of the top surface, said central pivot point being between first and second stability points, the first stability point being at the left side and the second stability point being at the right side, and also having a third stability point at a front portion of the bottom of the top surface, directly under the central part of the top surface where the user rests their foot, and a fourth stability point at a rear portion of the top surface, opposite to the front portion of the top surface, and a central pivot point from front to back in between the third stability point and the fourth stability point.
Patent MX-2020012492-A (MX)
Title: Compact vending machine.
Inventor: JAFA EMAD
IPC: G06Q10/08
Filed: 2019-05-20
Abstract: A compact vending machine for dispensing food products is disclosed. The compact vending machine includes a lightweight housing which may be mounted on a wall and a payment system that is configured to accept non-cash payments. A power source of the compact vending machine may be an external powers source, such as a power outlet, or an internal battery. An embodiment of the compact vending machine includes a controller and a communication system that are configured to transmit status information about the compact vending machine to a network.
Patent MX-2020013451-A (MX)
Title: Multiple reference intra prediction using variable weights.
Inventor: RACAPE FABIEN
IPC: H04N19/176
Filed: 2019-06-14
Abstract: A method of performing intra prediction for encoding or decoding uses multiple layers of reference samples. The layers are formed into reference arrays that are used by a function, such as a weighted combination, to form a final prediction. The weights can be variable, chosen from among a number of number of sets of weights. The prediction is used in encoding or decoding a block of video data. The weights can be determined in a number of ways, and for a given prediction mode, the same weights, or different weights can be used for all pixels in a target block. If the weights are varied, they can depend on the distance of the target pixel from reference arrays. An index can be sent indicating which set of weights is to be used.
Patent MX-2021000148-A (MX)
Title: Heterocyclic inhibitors of erk1 and erk2 and their use in the treatment of cancer.
Inventor: SMITH ROGER A
IPC: A61K31/506
Filed: 2017-11-14
Abstract: The present application provides novel heterocyclic compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful for inhibiting ERKl/2. By administering to a patient in need a therapeutically effective amount of one or more of the compounds of formula (I), wherein X, Y, Z, J, M, and R1 to R8 are defined herein, these compounds are effective in treating conditions associated with dysregulation of the RAS/RAF/MEK/ERK pathway. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer.
Patent MX-2021001228-A (MX)
Title: Composition for use in the prevention and/or treatment of the genitourinary mucosa.
Inventor: RODRIGUEZ VILABOA DEBORAH
IPC: A61K31/047
Filed: 2019-07-31
Abstract: The present invention refers to a composition for use in the prevention and/or treatment of a medical condition affecting the urogenital mucosa. It also refers to the use of said composition for preparing a medicament for the prevention and/or treatment of said condition. Furthermore, it refers to a method of preventing and/or treating said condition in which said composition is administered to a subject in need thereof.
Patent MX-2021003907-A (MX)
Title: Optimized hydraulic lifting jack.
Inventor: TAMER MANZUR Eduardo
IPC: B66F3/24
Filed: 2021-04-05
Abstract: The present invention relates to a bottle-type hydraulic jack that comprises a main body formed by a base intended to rest on the ground or other applicable surface, a central guide that rises on the bottom, and a receptacle/container to house the hydraulic fluid. Also, it includes a main piston (shaft or piston) or a secondary piston (rod or piston) that expands or contracts for the principal guide to cause the lifting and lowering of the load. Said secondary piston has an upper portion intended to contact the pack and exert pressure on it. When the piston does not reach said pack, the secondary piston expands to get the charge and push on it.
Patent MX-2021008558-A (MX)
Title: Method and system of identifying and quantifying antibody fragmentation.
Inventor: WANG SHUNHAI
IPC: G01N30/34
Filed: 2020-01-15
Abstract: Methods for identifying and quantifying antibody fragments and identifying the site of fragmentation on an antibody in a sample comprising the steps of loading a sample including fragments of the antibody into a chromatography system having a mixed-mode size-exclusion stationary phase (110), washing said mixed-mode size-exclusion stationary phase using a mobile phase to provide an eluent comprising said fragments, determining the molecular weight of said fragments using a mass spectrometer (120), and correlating said molecular weight to known protein standards.
Patent MX-2021012326-A (MX)
Title: Novel oxadiazole compounds for controlling or preventing phytopathogenic fungi.
Inventor: AUTKAR SANTOSH SHRIDHAR
IPC: C07D419/12
Filed: 2020-04-07
Abstract: The present invention discloses a compound of formula (I), Formula (I) wherein, R<sup>1</sup>, L<sup>1</sup>,A, L<sup>2</sup>, W<sup>1</sup>, R<sup>2f</sup>, R<sup>3f</sup>, Q, and R<sup>10</sup> are as defined in the detailed description. The present invention also relates to a process for preparing the compound of formula (I).
Patent MX-2021015511-A (MX)
Title: Pyrazine carbamates and their use as glun2b receptor modulators.
Inventor: GELIN CHRISTINE
IPC: A61P25/00
Filed: 2020-06-12
Abstract: Pyridine carbamates, pharmaceutical compositions containing pyridine carbamates, and uses of the pyridine carbamates and pharmaceutical compositions for modulating GluN2B receptors and for treating diseases, disorders, and medical conditions mediated by GluN2B receptor activity.